In vivo characterization of brain morphometric and metabolic endophenotypes in three inbred strains of mice using magnetic resonance techniques

Behavior Genetics

Volumn 36, Issue 5, 2006, Pages 732-744

  Penet, Marie France ^a   Laigle, Christophe ^a   Fur, Yann Le ^a   Confort Gouny, Sylviane ^a   Heurteaux, Catherine ^b   Cozzone, Patrick J ^a   Viola, Angèle ^a  

^a University of Aix Marseille   (France)

^b INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Brain; Magnetic resonance imaging (MRI); Magnetic resonance spectroscopy (MRS); Mouse strains; Neurochemistry; Neurology; Psychiatry

Indexed keywords

BIOLOGICAL MARKER; CHOLINE; MYELIN; N ACETYLASPARTIC ACID; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ARTICLE; AUTISM; BEHAVIORAL RESEARCH; BRAIN DISEASE; BRAIN METABOLISM; BRAIN VENTRICLE; CEREBELLUM; COGNITION; COMPARATIVE STUDY; DEPRESSION; ENDOPHENOTYPE; GENE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ENGINEERING; GENETIC MODEL; GENETIC SELECTION; GENETIC VARIABILITY; HIGH ENERGY PHOSPHATE; HIPPOCAMPUS; HISTOCHEMISTRY; HISTOPATHOLOGY; IN VIVO STUDY; INBRED STRAIN; MALE; MEMBRANE; MENTAL DISEASE; METABOLIC PARAMETERS; MORPHOMETRICS; MOUSE; MOUSE STRAIN; NEUROANATOMY; NEUROLOGY; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; PHENOTYPIC VARIATION; SCHIZOPHRENIA;

ANIMALS; BRAIN; MAGNETIC RESONANCE IMAGING; METABOLISM; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; PHENOTYPE;

EID: 33746903523     PISSN: 00018244     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10519-006-9077-4     Document Type: Article

References (86)

1. 13C] NMR spectroscopy. Neurochem Int 47:143-151
2. Anagnostopoulos AV, Mobraaten LE, Sharp JJ, Davisson MT (2001) Transgenic and knockout databases: behavioral profiles of mouse mutants. Physiol Behav 73:675-689
3. Antonova E, Sharma T, Morris R, Kumari V (2004) The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res 70:117-145
4. 31P NMR. Magn Reson Med 1:307-315
5. Baslow MH (2002) Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem Int 40:295-300
6. Baslow MH (2003) N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 28:941-953
7. Bauman ML, Kemper TL (2005) Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci 23:183-187
8. Belichenko PV, Masliah E, Kleschevnikov AM, Villar AJ, Epstein CJ, Salehi A, Mobley WC (2004) Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome. J Comp Neurol 480:281-298
9. Brambilla P, Hardan A, di Nemi SU, Perez J, Soares JC, Barale F (2003) Brain anatomy and development in autism: review of structural MRI studies. Brain Res Bull 61:557-569
10. Carper RA, Courchesne E (2005) Localized enlargement of the frontal cortex in early autism. Biol Psychiatry 57:126-133
11. Choi IY, Lee SP, Guilfoyle DN, Helpern JA (2003) In vivo NMR studies of neurodegenerative diseases in transgenic and rodent models. Neurochem Res 28:987-1001
12. Confort-Gouny S, Vion-Dury J, Nicoli F, Dano P, Donnet A, Grazziani N, Gastaut JL, Grisoli F, Cozzone PJ (1993) A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases. J Neurol Sci 118:123-133
13. Courchesne E, Saitoh O, Townsend JP, Yeung-Courchesne R, Press GA, Lincoln AJ, Haas RH, Schriebman L (1994) Cerebellar hypoplasia and hyperplasia in infantile autism. Lancet 343:63-64
14. Cowan WM, Kopnisky KL, Hyman SE (2002) The human genome project and its impact on psychiatry. Annu Rev Neurosci 25:1-50
15. Crnic L, Pennington B (2000) Down syndrome: neuropsychology and animal model. Prog Infan Res 1:61-111
16. Csernansky JG, Wang L, Swank J, Miller JP, Gado M, McKeel D, Miller MI, Morris JC (2005) Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage 25:783-792
17. Dager SR, Friedman SD, Heide A, Layton ME, Richards T, Artru A, Strauss W, Hayes C, Posse S (1999) Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. Arch Gen Psychiatry 56:70-77
18. Dager SR, Strauss WL, Marro KI, Richards TL, Metzger GD, Artru AA (1995) Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am J Psychiatry 152:666-672
19. Dierssen M, Fotaki V, Martinez de Lagran M, Gratacos M, Arbones M, Fillat C, Estivill X (2002) Neurobehavioral development of two mouse lines commonly used in transgenic studies. Pharmacol Biochem Behav 73:19-25
20. Evans KL, Muir WJ, Blackwood DH, Porteous DJ (2001) Nuts and bolts of psychiatric genetics: building on the Human Genome Project. Trends Genet 17:35-40
21. Fava M, Kendler KS (2000) Major depressive disorder. Neuron 28:335-341
22. Fiehn O (2002) Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol 48:155-171
23. Flint J, Wilkie AO, Buckle VJ, Winter RM, Holland AJ, McDermid HE (1995) The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet 9:132-140
24. Frangou S, Chitins X, Williams SC (2004) Mapping IQ and gray matter density in healthy young people. Neuroimage 23:800-805
25. Galanaud D, Nicoli F, Le Fur Y, Guye M, Ranjeva JP, Confort-Gouny S, Viout P, Soulier E, Cozzone PJ (2003) Multimodal magnetic resonance imaging of the central nervous system. Biochimie 85:905-914
26. Ganesh S, Delgado-Escueta AV, Sakamoto T, Avila MR, Machado-Salas J, Hoshii Y, Akagi T, Gomi H, Suzuki T, Amano K, Agarwala KL, Hasegawa Y, Bai DS, Ishihara T, Hashikawa T, Itohara S, Cornford EM, Niki H, Yamakawa K (2002) Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum Mol Genet 11:1251-1262
27. Gill SS, Small RK, Thomas DG, Patel P, Porteous R, Van Bruggen N, Gadian DG, Kauppinen RA, Williams SR (1989) Brain metabolites as 1H NMR markers of neuronal and glial disorders. NMR Biomed 2:196-200
28. Gordon JA, Hen R (2004) Genetic approaches to the study of anxiety. Annu Rev Neurosci 27:193-222
29. Green EL (1966) Biology of the laboratory mouse. McGraw-Hill, New-York
30. Green EL (1981) Genetics and probability in animal breeding experiments. MacMillan, London
31. Griffin JL (2004) Metabolic profiles to define the genome: can we hear the phenotypes? Philos Trans R Soc Lond B Biol Sci 359:857-871
32. Griffin JL, Cemal CK, Pook MA (2004) Defining a metabolic phenotype in the brain of a transgenic mouse model of spinocerebellar ataxia 3. Physiol Genomics 16:334-340
33. Guimera J, Casas C, Pucharcos C, Solans A, Domenech A, Planas AM, Ashley J, Lovett M, Estivill X, Pritchard MA (1996) A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region. Hum Mol Genet 5:1305-1310
34. Heintz N, Norman D, Gao W-Q, Hatten M (1993) Neurogenetic approaches to mammalian brain development. In: Tilghman Da (ed) Genome maps and neurological disorders. Cold Spring Harbor Press, Cold Spring Harbor, pp 19-44
35. Hock C, Konietzko U, Streffer JR, Tracy J, Signorell A, Muller-Tillmanns B, Lemke U, Henke K, Moritz E, Garcia E, Wollmer MA, Umbricht D, de Quervain DJ, Hofmann M, Maddalena A, Papassotiropoulos A, Nitsch RM (2003) Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron 38:547-554
36. Holowenko D, Peeling J, Sutherland G (1992) 1H NMR properties of N-acetylaspartylglutamate in extracts of nervous tissue of the rat. NMR Biomed 5:43-47
37. Hoogenraad CC, Koekkoek B, Akhmanova A, Krugers H, Dortland B, Miedema M, van Alphen A, Kistler WM, Jaegle M, Koutsourakis M, Van Camp N, Verhoye M, van der Linden A, Kaverina I, Grosveld F, De Zeeuw CI, Galjart N (2002) Targeted mutation of Cyln2 in the Williams syndrome critical region links CLIP-115 haploinsufficiency to neurodevelopmental abnormalities in mice. Nat Genet 32:116-127
38. Hyman S (2000) Mental illness: genetically complex disorders of neural circuitry and neural communication. Neuron 28:321-323
39. 31P magnetic resonance spectroscopy study. Biol Psychiatry 54:491-494
40. Jenkins BG, Klivenyi P, Kustermann E, Andreassen OA, Ferrante RJ, Rosen BR, Beal MF (2000) Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. J Neurochem 74:2108-2119
41. 31P-MRS chemical shift imaging study at 4 Tesla. Br J Psychiatry 184:409-415
42. Kandel ER, Squire LR (2000) Neuroscience: breaking down scientific barriers to the study of brain and mind. Science 290:1113-1120
43. Kesner RP, Lee I, Gilbert P (2004) A behavioral assessment of hippocampal function based on a subregional analysis. Rev Neurosci 15:333-351
44. Kreis R, Ernst T, Ross BD (1993) Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 30:424-437
45. Kreis R, Hofmann L, Kuhlmann B, Boesch C, Bossi E, Huppi PS (2002) Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 48:949-958
46. Lalonde R, Strazielle C (2003) The effects of cerebellar damage on maze learning in animals. Cerebellum 2:300-309
47. Lei H, Zhang Y, Zhu XH, Chen W (2003) Changes in the proton T2 relaxation times of cerebral water and metabolites during forebrain ischemia in rat at 9.4 T. Magn Reson Med 49:979-984
48. Lewis DA, Levitt P (2002) Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25:409-432
49. Lewis DA, Lieberman JA (2000) Catching up on schizophrenia: natural history and neurobiology. Neuron 28:325-334
50. Manton DJ, Lowry M, Blackband SJ, Horsman A (1995) Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours. NMR Biomed 8:104-112
51. Matynia A, Kushner SA, Silva AJ (2002) Genetic approaches to molecular and cellular cognition: a focus on LTP and learning and memory. Annu Rev Genet 36:687-720
52. Mayford M, Mansuy IM, Muller RU, Kandel ER (1997) Memory and behavior: a second generation of genetically modified mice. Curr Biol 7:R580-R589
53. Middleton FA, Strick PL (1998a) Cerebellar output: motor and cognitive channels. Trends Cognit Sci 2:348-354
54. Middleton FA, Strick PL (1998b) The cerebellum: an overview. Trends Neurosci 21:367-369
55. Milner B, Squire LR, Kandel ER (1998) Cognitive neuroscience and the study of memory. Neuron 20:445-468
56. 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Biol Psychiatry 33:762-773
57. Moolenaar SH, Engelke UF, Wevers RA (2003) Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann Clin Biochem 40:16-24
58. Morley KI, Montgomery GW (2001) The genetics of cognitive processes: candidate genes in humans and animals. Behav Genet 31:511-531
59. Mouse-Genome-Sequencing-Consortium (2002) Initial sequencing and comparative analysis of the mouse genome. Nature 420:520-562
60. Neiderhiser JM, Plomin R, McClearn GE (1992) The use of CXB recombinant inbred mice to detect quantitative trait loci in behavior. Physiol Behav 52:429-439
61. Nicholson JK, Connelly J, Lindon JC, Holmes E (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153-161
62. O'Keefe J, Nadel L (1978) The hippocampus as a cognitive map. Oxford University Press, Oxford
63. Pandurangi AK, Dewan MJ, Lee SH, Ramachandran T, Levy BF, Boucher M, Yozawitz A, Major L (1984) The ventricular system in chronic schizophrenic patients. A controlled computed tomography study. Br J Psychiatry 144:172-176
64. Passani LA, Vonsattel JP, Carter RE, Coyle JT (1997) N- acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases. Mol Chem Neuropathol 31:97-118
65. Pellerin L, Magistretti PJ (2004) Neuroenergetics: calling upon astrocytes to satisfy hungry neurons. Neuroscientist 10:53-62
66. Penet MF, Viola A, Confort-Gouny S, Le Fur Y, Duhamel G, Kober F, Ibarrola D, Izquierdo M, Coltel N, Gharib B, Grau GE, Cozzone PJ (2005) Imaging experimental cerebral malaria in - vivo: significant role of ischemic brain edema. J Neurosci 25:7352-7358
67. Pettegrew JW, Panchalingam K, Klunk WE, McClure RJ, Muenz LR (1994) Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study. Neurobiol Aging 15:117-132
68. Pouwels PJ, Frahm J (1997) Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed 10:73-78
69. Raz S, Raz N (1990) Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging. Psychol Bull 108:93-108
70. 2 relaxation times in rat brain and in rat brain tumors implanted to nude mice. Magn Reson Med 4:144-152
71. Rodriguez LA, Plomin R, Blizard DA, Jones BC, McClearn GE (1995) Alcohol acceptance, preference, and sensitivity in mice. II. Quantitative trait loci mapping analysis using BXD recombinant inbred strains. Alcohol Clin Exp Res 19:367-373
72. Ross B, Bluml S (2001) Magnetic resonance spectroscopy of the human brain. Anat Rec 265:54-84
73. Schmahmann J (1998) Dysmetria of thought; clinical consequences of cerebella dysfunction on cognistion and affect. Trends Cognit Sci 2:362-371
74. Schwarcz A, Natt O, Watanabe T, Boretius S, Frahm J, Michaelis T (2003) Localized proton MRS of cerebral metabolite profiles in different mouse strains. Magn Reson Med 49:822-827
75. Shin JC, Ivry RB (2003) Spatial and temporal sequence learning in patients with Parkinson's disease or cerebellar lesions. J Cogn Neurosci 15:1232-1243
76. Simpson EM, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, Sharp JJ (1997) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet 16:19-27
77. Styner M, Lieberman JA, McClure RK, Weinberger DR, Jones DW, Gerig G (2005) Morphometric analysis of lateral ventricles in schizophrenia and healthy controls regarding genetic and disease-specific factors. Proc Natl Acad Sci USA 102:4872-4877
78. Taketo M, Schroeder AC, Mobraaten LE, Gunning KB, Hanten G, Fox RR, Roderick TH, Stewart CL, Lilly F, Hansen CT et al. (1991) FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci USA 88:2065-2069
79. Torres G, Meeder BA, Hallas BH, Spernyak JA, Mazurchuk R, Jones C, Gross KW, Horowitz JM (2005) Ventricular size mapping in a transgenic model of schizophrenia. Brain Res Dev Brain Res 154:35-44
80. Tsaih SW, Lu L, Airey DC, Williams RW, Churchill GA (2005) Quantitative trait mapping in a diallel cross of recombinant inbred lines. Mamm Genome 16:344-355
81. Urenjak J, Williams SR, Gadian DG, Noble M (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocytetype-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59:55-61
82. Veenstra-Vanderweele J, Christian SL, Cook EH Jr (2004) Autism as a paradigmatic complex genetic disorder. Annu Rev Genomics Hum Genet 5:379-405
83. Viola A, Chabrol B, Nicoli F, Confort-Gouny S, Viout P, Cozzone PJ (2002) Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia. Pediatr Res 52:292-300
84. Viola A, Nicoli F, Denis B, Confort-Gouny S, Le Fur Y, Ranjeva JP, Viout P, Cozzone PJ (2004) High cerebral scyllo-inositol: a new marker of brain metabolism disturbances induced by chronic alcoholism. Magma 17:47-61
85. Wu CL, Melton DW (1993) Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice. Nat Genet 3:235-240
86. Yacubian J, de Castro CC, Ometto M, Barbosa E, de Camargo CP, Tavares H, Cerri GG, Gattaz WF (2002) 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophr Res 58:117-122